Searched over 200M research papers
10 papers analyzed
These studies suggest that pain after a stroke is common, can be persistent or episodic, and significantly affects the quality of life for stroke survivors.
15 papers analyzed
20 papers analyzed
Post-stroke pain is a common and significant issue affecting stroke survivors. Studies indicate that pain occurs in 19-74% of patients following a stroke, with various types of pain manifesting due to the brain lesion itself or other complications . Chronic pain is increasingly recognized as a consequence of stroke, with a higher prevalence in stroke patients compared to the general population.
Central post-stroke pain (CPSP) is a direct result of the brain lesion caused by the stroke. Although its prevalence is relatively low (1-8%), CPSP is often persistent and difficult to treat, significantly impacting the quality of life of affected individuals . The pain is typically described as burning or sharp and can be exacerbated by factors such as cold or stress.
Musculoskeletal pain, including shoulder pain and pain related to spasticity, is common among stroke survivors. This type of pain often results from musculoskeletal disorders or complications such as shoulder subluxation and can lead to chronic suffering and functional loss .
Headaches and other pain syndromes, such as complex regional pain syndrome and tension-type headaches, are also reported among stroke patients. These conditions can be persistent and vary in intensity, further complicating the rehabilitation process .
The exact mechanisms underlying post-stroke pain are not fully understood. However, it is suggested that hyperexcitation in damaged sensory pathways and damage to central inhibitory pathways may play a role in the development of CPSP. Additionally, pain can be a result of spasticity, musculoskeletal issues, or other stroke-related complications .
Post-stroke pain can present in various forms, including episodic, transient, or persistent pain. It often accompanies other debilitating symptoms such as hemiparesis and can significantly impair the quality of life and functional outcomes of stroke survivors . Pain is frequently underdiagnosed and undertreated, despite its association with depression, cognitive dysfunction, and reduced quality of life .
Adrenergic antidepressants are commonly used as the first-line treatment for CPSP, although their effectiveness is often incomplete. Antiepileptics like lamotrigine and GABAergic drugs such as gabapentin or pregabalin have shown potential as adjunctive therapies. Pain management often requires a multidisciplinary approach, combining pharmacological and physical treatments .
Non-pharmacological treatments, including physical therapy, movement therapy, heat and cold therapies, and transcutaneous electrical nerve stimulation (TENS), can be effective in managing pain related to spasticity or musculoskeletal disorders. Motor cortex stimulation and deep brain stimulation have also shown promise in certain patient groups .
Pain is a frequent and multifaceted consequence of stroke, affecting a significant proportion of stroke survivors. It can manifest in various forms, including CPSP, musculoskeletal pain, and headaches, and is often associated with other debilitating symptoms. Effective pain management requires a comprehensive approach, combining pharmacological and non-pharmacological treatments to improve the quality of life and functional outcomes for stroke survivors. Further research is needed to better understand the pathophysiology of post-stroke pain and develop more effective treatment modalities.
Most relevant research papers on this topic